Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
Conditions: Liver Cancer Interventions: Device: transcutaneous electrical acupoint stimulation; Device: sham transcutaneous electrical acupoint stimulation Sponsors: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Conditions: Solid Tumor Interventions: Drug: HS-IT101 Injection Sponsors: Qingdao Sino-Cell Biomedicine Co., Ltd.; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; The First Hospital of Jilin University; West China Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Concurrent Programmed Cell Death Protein 1 Inhibitor and Radiotherapy With Immunonutrition Support for in Unresectable Esophageal Squamous Cell Carcinoma Patients
Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma; Sintilimab; Radiotherapy; Concurrent Chemoradiotherapy; Immunonutrition Interventions: Combination Product: Sintilimab + radiotherapy + enteral nutritional emulsion (TPF-T) Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan Liposome; Drug: 5-FU; Drug: LV; Drug: Bevacizumab Sponsors: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma; Sintilimab; Radiotherapy; Concurrent Chemoradiotherapy; Immunonutrition Interventions: Radiation: Radiotherapy; Drug: Programmed Cell Death Protein 1 Inhibitor; Dietary Supplement: Immunonutrition support Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.
Conditions: Gastric Cancer Interventions: Drug: Adebrelimab+Apatinib+Paclitaxel for Injection(Albumin Bound) Sponsors: Chinese PLA General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Management of PADIS in Emergency Intensive Care Unit: a Multicenter Cross-sectional Survey
Conditions: Pain, Agitation-sedation, Delirium, Immobility and Sleep Disruption Interventions: Behavioral: PADIS assessment Sponsors: Capital Medical University; Beijing Tiantan Hospital; The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Dalian Medical University; Fudan University; Affiliated hospital of Guilin medical university,China; The Second Affiliated Hospital of Hainan Medical University; The First Hospital of Hebei Medical University; The First Hospital of Jilin University; Southwest Hospital, China; General hospital of shenyang military command; Beijing Anzhen Hospital; M...
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
CT-based Model for Predicting Prolonged Weaning in Patients With Abdominal Trauma
Conditions: Wounds and Injuries; Ventilation Therapy; Complications Interventions: Device: mechanical ventilation Sponsors: Jinling Hospital, China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Management of PADIS in Emergency Intensive Care Unit
Conditions: Pain; Agitation, Emergence; Delirium; Critical Illness Interventions: Behavioral: PADIS assessment Sponsors: Capital Medical University; Beijing Tiantan Hospital; The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Dalian Medical University; Fudan University; Affiliated hospital of Guilin medical university,China; The Second Affiliated Hospital of Hainan Medical University; The First Hospital of Hebei Medical University; The First Hospital of Jilin University; Southwest Hospital, China; General hospital of shenyang military command; Beijing Anzhen Hospital; Mianyang Centr...
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT
DiscussionPROSPECT aims to assess the safety and efficacy of a BDQ-containing SCR MDR-TB treatment at seventeen sites across China, while also providing high-quality data to guide SCRs administration under the direction of the China National Tuberculosis Program for MDR-TB. Additionally, PROSPECT will explore the potential benefits of extending the administration of the 9-month BDQ-containing SCR for participants without sputum conversion by week 16.Trial registrationClinicalTrials.gov NCT05306223. Prospectively registered on 16 March 2022 athttps://clinicaltrials.gov/ct2/show/NCT05306223?term=NCT05306223&draw=1&ra...
Source: Trials - April 1, 2024 Category: Research Source Type: clinical trials
A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive Melanoma
Conditions: BRAF V600 Mutation Positive Melanoma Sponsors: Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou)
Conditions: Tumor, Solid Interventions: Device: Proton Radiation Therapy System (ProBeam) Sponsors: Varian, a Siemens Healthineers Company Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy
Conditions: Breast Cancer; Neoplasm, Breast; Patient Participation; Mental Health Issue Interventions: Behavioral: Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy Sponsors: Taipei City Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study
Conditions: Cardiovascular Disease; Type 2 Diabetes Mellitus Sponsors: Beijing Anzhen Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Establishment of Precise Nutrition Management Scheme for Patients With Prediabetes Based on Nutrigenomics
Conditions: Prediabetes Interventions: Behavioral: Precise nutritional intervention; Behavioral: Conventional nutritional intervention Sponsors: China-Japan Friendship Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
